T cells have a range of cytotoxic and immune-modulating functions, depending on activation state and 12 subtype. However, current methods to assess T cell function use exogenous labels that often require cell 13 permeabilization, which is limiting for time-course studies of T cell activation and non-destructive quality 14 control of immunotherapies. Label-free optical imaging is an attractive solution. Here, we use autofluores-15 cence imaging of NAD(P)H and FAD, co-enzymes of metabolism, to quantify optical imaging endpoints 16 in quiescent and activated T cells. Machine learning classification models were developed for label-free, 17 non-destructive determination of T cell activation state. T cells were isolated from the peripheral blood of 18 human donors, and a subset were activated with a tetrameric antibody against CD2/CD3/CD28 surface 19 ligands. NAD(P)H and FAD autofluorescence intensity and lifetime of the T cells were imaged using 20 a multiphoton fluorescence lifetime microscope. Significant differences in autofluorescence imaging end-21 points were observed between quiescent and activated T cells. Feature selection methods revealed that 22 the contribution of the short NAD(P)H lifetime (α1) is the most important feature for classification of 23 activation state, across multiple donors and T cell subsets. Logistic regression models achieved 97-99% 24 accuracy for classification of T cell activation from the autofluorescence imaging endpoints. Additionally, 25 autofluorescence imaging revealed NAD(P)H and FAD autofluorescence differences between CD3 + CD8 + 26 and CD3 + CD4 + T cells, and random forest models of the autofluorescence imaging endpoints achieved 27 97+% accuracy for four-group classification of quiescent and activated CD3 + CD8 + and CD3 + CD4 + T 28 1 cells. Altogether these results indicate that autofluorescence imaging of NAD(P)H and FAD is a powerful 29 method for label-free, non-destructive determination of T cell activation and subtype, which could have 30 important applications for the treatment of cancer, autoimmune, infectious, and other diseases. 31 1 Introduction 32 T cells are an important component of the adaptive immune response and have diverse cytotoxic and immune-33 modulating, or "helper" activities, upon activation. The two main T cell subtypes are CD3 + CD8 + T cells 34 that engage in cell-mediated cytotoxicity and release toxic cytokines, including interferon gamma (IFN-γ) 35 and tumor necrosis factor alpha (TNF-α), and CD3 + CD4 + T cells that can be further divided into additional 36 subtypes with differing pro-and anti-inflammatory functions due to chemokine and cytokine production[1, 2]. 37 T cells are a promising target for immunotherapies because of these diverse functions. Immunotherapies that 38 directly increase T cell cytotoxic activity, such as immune checkpoint blockade therapies and adoptive cell 39 transfer therapies, are currently used clinically for cancer treatment and are in development for additional 40 diseases including HIV[3, 4]. Immunotherapies that enhance regulatory T cell (T RE G ) behaviors are in 41 development to treat transplant rejection and autoimmune diseases, including diabetes and Crohn's disease 42 [5-7]. Due to the variable behaviors of T cell subsets, full evaluation of immunotherapy efficacy requires 43 profiling of T cell subtypes and activation states to assess the impact of different T cell compartments on 44 the patient, select for appropriate therapeutic cell populations, and evaluate the degree of response upon 45 stimulation. 46 New tools that are non-destructive and label-free are needed to fully characterize T cells for assessment of 47 immunotherapies. Currently, T cell subtype and function is determined from expression of surface proteins 48 (e.g. CD3, CD4, CD8, CD45RA, etc.) and cytokine production (e.g. IFN-γ, TGF-β, IL-2, IL-4, IL-17, etc.) 49 by antibody-based methods such as flow cytometry, immunohistochemistry, or immunofluorescence, or by 50 transgenic fluorophore expression. However, all of these methods require exogenous contrast agents, and flow 51 cytometry and immunohistochemistry require tissue dissociation and fixation, respectively. A non-destructive 52 and label-free method of determining T cell activity would enable direct observation of T cell behavior and 53 immunotherapy effects in vivo in preclinical models of cancer. Additionally, such a tool could be amenable 54 for single-cell quality control of adoptive T cell therapies, where T cells, expanded in vitro, are injected into 55 the patient. Autofluorescence imaging is an attractive method to probe immune cell behaviors because it is 56 non-destructive, relies on endogenous contrast, and provides high spatial and temporal resolution. 57 Fluorescence imaging of the endogenous metabolic co-enzymes NAD(P)H and FAD provides quantitative 58 endpoints of cellular metabolism [8-10]. (NADH and NADPH fluorescence are indistinguishable; therefore, 59 2 NAD(P)H is used to represent the combined fluorescence signal[11].) The optical redox ratio is the fluo-60 rescence intensity of NAD(P)H divided by the sum of the fluorescence intensities of NAD(P)H and FAD, 61 and provides an optical measurement of the redox state of the cell [8, 12]. The fluorescence lifetime, the 62 time the fluorophore is in the excited state before returning to ground state, provides information on the 63 protein binding of NAD(P)H and FAD [9, 13]. NAD(P)H and FAD can both exist in two conformations: a 64 quenched and unquenched form, with a short and long lifetime, respectively. NAD(P)H has a short lifetime 65 in the free state and a long lifetime in its protein-bound state [9]. Conversely, FAD has a short lifetime 66 when bound to an enzyme and a long lifetime when free [13]. Fluorescence lifetime imaging (FLIM) allows 67 quantification of the short (τ 1 ) and long (τ 2 ) lifetime values, the fraction of free and protein-bound co-enzyme 68 (α 1 and α 2 , respectively, for NAD(P)H, and α 2 and α 1 , respectively, for FAD), and the mean lifetime (the 69 weighted average of the short and long lifetimes, τ m = α 1 * τ 1 + α 2 * τ 2 ). The fluorescence intensity and 70 lifetime of NAD(P)H and FAD are sensitive to metabolic differences between neoplasias and malignant tis-71 sues, anti-cancer drug effects in cancer cells, and differentiating stem cells [14-19]. Autofluorescence imaging 72 has been used previously to identify macrophages in vivo and detect metabolic changes due to macrophage 73 polarization [20-22]. Altogether, fluorescence lifetime imaging of NAD(P)H and FAD provide quantitative 74 and functional endpoints of cellular metabolism. 75 T cells undergo metabolic reprogramming when activated by an antigen. Upon activation, T cells have 76 increased metabolic demands to support cell growth, proliferation, and differentiation [23]. CD28 stimulation 77 induces glucose uptake and glycolysis in T cells through upregulation of GLUT1, phosphatidylinositol 3'-78 kinase (PI3K), and Akt. This metabolic state of increased aerobic glycolysis is required for T cells to maintain 79 effector function [23-25]. Therefore, this study tests the hypothesis that fluorescence lifetime imaging of 80 NAD(P)H and FAD provides a label-free, non-destructive method with quantitative endpoints to identify 81 activated T cells. To test this hypothesis, we isolated T cells from the blood of healthy donors, activated 82 the cells in an antigen-independent manner with a tetrameric antibody (anti-CD2/CD3/CD28) and imaged 83 the NAD(P)H and FAD fluorescence intensity and lifetime of quiescent and activated T cells. This is the 84 first study to (1) demonstrate autofluorescence lifetime differences between quiescent and activated T cells 85 and (2) accurately classify T cell activation state from machine learning models using quantitative endpoints 86 from autofluoresence lifetime images. 87 3 2 Results 88 2.1 Autofluorescence imaging reveals metabolic differences with activation in 89 T cells.
A Figure 1 : NAD(P)H and FAD autofluorescence imaging reveals metabolic differences between quiescent and activated T cells. Representative optical redox ratio, NAD(P)H τ m , and FAD τ m images of quiescent (columns 1, 3) and activated (columns 2, 4) CD3 + (rows 1-3) and CD3 + CD8 + (row 4-6) T cells from two different donors. Scale bar is 20 µm. Cell size (B), optical redox ratio (C), NAD(P)H τ m (D), FAD τ m (E), NAD(P)H α 1 (F), and FAD α 1 (G) of quiescent and activated CD3 + and CD3 + CD8 + T cells. Black circles represent mean of all data (6 donors (ECAR, panel I) are increased in activated bulk CD3 + and isolated CD3 + CD8 + T cells. The ratio of OCR to ECAR (J) is significantly decreased in activated bulk CD3 + and isolated CD3 + CD8 + T cells as compared with that of quiescent T cells. *** p<0.001, Student's t-test, n = 6 wells/group CD3 + CD8 + isolation, n = 12 wells/group CD3 + isolation.
2.2 Machine learning models of autofluorescence imaging endpoints allow clas-116 sification of quiescent and activated T cells with high accuracy. 117 Uniform Manifold Approximate and Projection (UMAP) [26] , a dimension reduction technique similar to 118 tSNE, was used to visualize how cells cluster from autofluorescence measurements. Neighbors were defined 119 through a cosine distance function computed across the autofluorescence endpoints (optical redox ratio, 120 NAD(P)H τ m , NAD(P)H τ 1 , NAD(P)H τ 2 , NAD(P)H α 1 , FAD τ m , FAD τ 1 , FAD τ 2 , and FAD α 1 ) and 121 cell size for each cell. UMAP was chosen over other techniques, notably PCA or tSNE, for its speed, ability 122 to include non-metric distance functions, and performance on preserving the global structure of the data. 123 UMAP representations of the autofluorescence imaging data reveals separation of quiescent and activated 124 T cells ( Fig. 2A-B ). The gain ratio of autofluorescence endpoints indicates that NAD(P)H α 1 , cell size, 125 and optical redox ratio are the most important features for classification of activation state of CD3 + T 126 cells (Fig. 2C ), and NAD(P)H α 1 , optical redox ratio, and NAD(P)H τ m are the most important features 127 for classification of activation state of CD3 + CD8 + T cells (Fig. 2C ). The order of feature importance was 128 consistent across multiple feature selection methods including information gain, χ 2 , and random forest ( Fig. α 1 achieved a slightly lower accuracy of 0.965 ( Fig. 2E ). Models that include cell size or cell size and the 148 optical redox ratio, endpoints that can be obtained from fluorescence intensity images, were less effective 149 at accurately predicting activation of bulk CD3 + T cells with ROC AUCs of 0.708 and 0.901, respectively 150 ( Fig. 2E ). Similar results were obtained for the isolated CD3 + CD8 + T cells, with the highest ROC AUC 151 values achieved for logistic regression classification models using all 10 autofluorescence imaging endpoints 152 and NAD(P)H α 1 alone, AUC = 0.996 and 0.994, respectively ( Fig. 2F ). Similar classification accuracy 153 was achieved with random forest and support vector machine models using all 10 autofluorescence imaging 154 endpoints ( Fig. S9 ).
155
Figure 2: Autofluorescence imaging endpoints allow classification of quiescent and activated T cells. (A-B) UMAP data reduction technique allows visual representation of the separation between quiescent ("Q") and activated ("Act") bulk CD3 + (A) and isolated CD3 + CD8 + (B) T cells. Each color shade corresponds to a different donor, grays correspond to quiescent cells and green or purple to activated CD3 + or CD3 + CD8 + T cells, respectively. (C) Feature weights for classification of quiescent versus activated T cells by the gain ratio method. (D) ROC curves for logistic regression models for classification of activation state within bulk CD3 + T cells, bulk CD3 + T cells normalized within each donor (CD3 + Norm), isolated CD3 + CD8 + T cells, and isolated CD3 + CD8 + T cells normalized within each donor (CD3 + CD8 + Norm). (E-F) ROC curves for logistic regression classification models computed using different features for the classification of (E) quiescent or activated bulk CD3 + or (F) isolated CD3 + CD8 + T cells. Models were trained on cells that lacked same cell validation data from donors A, B, C, and D but were known to be quiescent or activated by culture conditions (n = 4131 CD3 + cells, n = 2655 CD3 + CD8 + cells), and cells from donors B, E, and F with CD69 validation of activation state were used to test the models (n = 696 CD3 + cells, n = 595 CD3 + CD8 + cells). 7 2.3 Autofluorescence imaging reveals T cell heterogeneity within and across 156 donors.
157
T cell heterogeneity was assessed within and across donors ( Fig. 3 ). Heatmap representation (Fig. 3A ) of 158 the z-score of autofluorescence imaging endpoint values at the donor level (each row is the mean data of a 159 single donor, cell type, and activation) reveals that the T cells cluster by activation state (i.e. quiescent and 160 activated cluster separately) and isolation (bulk CD3 + or isolated CD3 + CD8 + ). Corresponding coefficient 161 of variation heatmaps highlight the high intra-donor variability of the size of activated T cells and low 162 intra-donor heterogeneity of the autofluorescence endpoints ( Fig. S10 ).
163
A representative z score heatmap where each row is a single cell from one donor reveals distinct clusters 3C, S11-12). For example, histograms of the NAD(P)H τ m values of quiescent and activated CD3 + CD8 + T 168 cells reveals a bimodal population within the quiescent CD3 + CD8 + T cells, with one peak of the quiescent 169 cells consistent with the peak of the activated cells ( Fig. 3C ). 170 We hypothesized that memory and naïve T cells within the quiescent population contributed to the ob-171 served heterogeneity within the quiescent CD3 + CD8 + T cell population ( Fig. 3B -C, S11-13) (i.e. the multiple 172 clusters of quiescent CD3 + CD8 + cells within the heatmaps and bimodal distribution of the NAD(P)H τ m 173 of quiescent CD3 + CD8 + T cells). To test this, we co-stained quiescent CD3 + CD8 + T cells with antibodies 174 against CD45RA, a marker of naïve T cells, and CD45RO, a marker of memory T cells. NAD(P)H τ m was 175 significantly decreased in CD45RO + cells as compared with NAD(P)H τ m of CD45RA + cells ( Fig. 3D ).
176
Additionally, the optical redox ratio and NAD(P)H α 1 were increased (p<0.01) in CD45RO + CD3 + CD8 + 177 T cells as compared to CD45RA + cells ( Fig. S14 ). 
cells from 1 donor, ** p<0.01, -Act = quiescent cells, + Act = cells exposed to anti-CD3/CD2/CD28 for 48hr.) 9 CD3 + CD8 + population as compared to the corresponding values of quiescent and activated CD3 + CD8 + T 187 cells, respectively, within the bulk CD3 + population ( Fig. 4B -C). Additional differences in NAD(P)H and 188 FAD autofluorescence lifetime endpoints were observed between CD3 + CD8 + T cells within the bulk CD3 + 189 population and the isolated CD3 + CD8 + population (Fig. S15 ).
190
Despite these differences between CD3 + CD8 + T cells of CD3 + CD8 + specific isolations and bulk CD3 + four groups, when trained on 75% of the T cell observations and tested on the remaining 25% ( Fig. 4H ).
208
Classification accuracy scales with number of cells in train versus test groups (Fig. 4H ). Random forest 209 feature analysis revealed that NAD(P)H τ 2 is the highest weighted feature for the classification of activated 210 CD3 + CD4 + from activated CD3 + CD8 + T cells, and FAD τ 1 is the highest weighted feature for quiescent 211 CD3 + CD4 + from quiescent CD3 + CD8 + T cells ( Fig. S16B ). Stars between quiescent and activated boxplots compare quiescent and activated CD3 + CD8 + T cells within an isolation (CD3 + or CD3 + CD8 + ), stars above the quiescent box plot represent signficance between quiescent CD3 + CD8 + T cells from the bulk CD3 + and CD3 + CD8 + specific isolations, stars above the activated box plot represent signficance between activated CD3 + CD8 + T cells from the bulk CD3 + and CD3 + CD8 + specific isolations, ** p<0.01, *** p<0.001. (D) Accuracy of random forest classification of quiescent versus activated CD3 + CD8 + T cells from CD3 + CD8 + specific isolations (n=213 cells) and bulk CD3 + isolations (n=253 cells). (E) UMAP of NAD(P)H and FAD autofluorescence imaging endpoints of quiescent and activated CD3 + CD4 + and CD3 + CD8 + cells identified within bulk CD3 + populations. (F) NAD(P)H τ 2 of quiescent CD3 + CD4 + and CD3 + CD8 + cells (bulk CD3 + isolation, n=66 quiescent CD3 + CD4 + T cells, n=83 quiescent CD3 + CD8 + T cells, * p<0.05, *** p<0.001). (G) NAD(P)H α 1 of activated CD3 + CD4 + and CD3 + CD8 + cells (bulk CD3 + isolation, n=264 activated CD3 + CD4 + T cells, n=170 activated CD3 + CD8 + T cells). (H) Accuracy of random forest classification of CD3 + CD4 + and CD3 + CD8 + T cells from quiescent (2 group classification, "CD3 + Q"), activated (2 group classification, "CD3 + Act"), or both quiescent and activated T cells (4 group classification, "CD3 + All") within bulk CD3 + isolations, total observations include 66 quiescent CD3 + CD4 + T cells, 83 quiescent CD3 + CD8 + T cells, 264 activated CD3 + CD4 + T cells, and 170 activated CD3 + CD8 + T cells.
11
CD69 immunofluorescence overlaid in pink, demonstrates the difference in NAD(P)H α 1 between quiescent 217 (CD69 − ) and activated (CD69 + ) T cells (Fig. 5A ). UMAP visualization of the autofluorescence imaging 218 data reveals separation of quiescent and activated CD3 + T cells within this population of combined quiescent 219 and activated cells (Fig. 5B ). When cultured in isolated populations, quiescent and activated T cells have optical redox ratio of quiescent T cells, reflect a shift towards glycolysis in activated T cells (Fig. 1, S1 , with a shift from TCA metabolism to glycolysis [33] , which was verified by the Seahorse assay and metabolic 265 inhibitor experiment ( Fig. 1H-J, S5 ). The significant increase in the lifetime of free NAD(P)H (τ 1 , Fig. S1 ), clustering of T cells within the autofluorescence imaging dataset. One of these populations within the 275 quiescent CD3 + CD8 + population, was identified due to a difference in the mean NAD(P)H lifetime which 276 was found to be due to naïve (CD45RO + ) and memory (CD45RA + ) CD3 + CD8 + T cells (Fig. 3C-D) , 277 which are known to have differing metabolic states: memory T cells have increased glycolytic capacity and 278 mitochondrial mass as compared with naïve T cells [27] . An additional subpopulation was identified within 279 the activated T cell subset and characterized by larger than average cells (Fig. 3B, S6-7) . These large cells 280 may be actively dividing cells, a condition which is also accompanied by metabolic and autofluorescence 281 differences [38, 39] .
282
Machine learning approaches are powerful tools for classification of biomedical imaging data and have 283 been used on extracted morphological features of phase-contrast images to identify cancer cells from immune 284 cells, on brightfield images to assess cell cycle, and on phase contrast and autofluorescence images to classify 285 macrophage exposure to LPS [22, 40, 41] . Here, high ROC AUCs (0.95+) were achieved using machine 286 learning techniques to classify T cells as activated or quiescent using the autofluorescence imaging endpoints 287 (optical redox ratio, cell size, NAD(P)H τ m , NAD(P)H τ 1 , NAD(P)H τ 2 , NAD(P)H α 1 , FAD τ m , FAD 288 τ 1 , FAD τ 2 , and FAD α 1 ) quantified for each cell. Classification of activation of T cells from CD3 + CD8 + 289 specific isoations was slightly higher than that of T cells from bulk CD3 + isolations as might be expected for 290 a homogeneous population (CD3 + CD8 + ) rather than a heterogeneous population (bulk CD3 + populations 291 contain CD4 + and CD8 + subsets). Although multiple classification models were found to have similar 292 performance, logistic regression was the best fitting model, suggesting that the predicted probability of 293 activation is a linear combination of all 10 of the autofluorescence imaging endpoints. Interestingly, donor 294 normalization (Fig. 2D ) of the autofluorescence imaging endpoints did not improve classification accuracy, 295 suggesting that the autofluorescence endpoints reflect changes in T cells with activation that are consistent 296 across donors so generalized models can be used for unspecified donors or patients, which is beneficial for 297 robust implementation of autofluorescence imaging as a universal tool to evaluate T cell activation.
298
The models for classification of activation in T cells reported here have higher ROC AUC values than the 299 previously reported accuracy of 84-87% found for binary logistic regression classification of morphological 300 and Raman spectra features of control and LPS-exposed macrophages [22] . The increased accuracy obtained 301 in our study could be due to the metabolic information gained from the NAD(P)H and FAD autofluorescence and random forest), and different subsets of CD3 + , CD3 + CD8 + , and CD69 + /CD69 − T cells (Fig. 2C, S6 , 310 S19). The classification analysis also revealed that while models trained on all 10 autofluorescence imaging 311 15 endpoints yielded the highest accuracy for classification of activation state of T cells, logistic regression 312 using only NAD(P)H α 1 yielded comparably high ROC AUCs and was more accurate for predicting T cell 313 activation than cell size alone ( Fig. 2E ), or fluorescence intensity measurements (cell size + redox ratio), 314 which can be obtained by wide-field or confocal fluorescence microscopy. Additional label-free methods, CD3 + CD4 + population) suppress the activation and proliferation of other T cells [44, 45] . Differences in the 324 NAD(P)H and FAD autofluorescence imaging endpoints (Fig. 4 , S15) between CD3 + CD8 + T cells cultured 325 with and without CD3 + CD4 + T cells were observed, suggesting autofluorescence imaging is sensitive to 326 CD3 + CD4 + induced changes in CD3 + CD8 + T cells (Fig. 4) . However, despite these differences, NAD(P)H 327 α 1 remains the highest weighted feature for classification of activation state (Fig. S16) , and activation state of 328 CD3 + CD8 + T cells can be classified from autofluorescence imaging endpoints with high accuracy, regardless 329 of T cell population (Fig. 4D) .
330
Due to the differing physiological functions of CD3 + CD4 + and CD3 + CD8 + T cells [1, 46] CD3 + CD4 + from activated and quiescent CD3 + CD8 + accurately (Fig. 4H) . Although successful classifi-342 cation was achieved for CD3 + CD4 + versus CD3 + CD8 + T cells, these changes are much subtler than the 343 metabolic changes with activation, as evidenced by the increased number of cells needed to train the models 344 16 to achieve high classification accuracy (Fig. 4D,H) .
345
Autofluorescence lifetime imaging has spatial and temporal resolution advantages over traditional assays 346 to survey T cell activation and function. Autofluorescence imaging can be high resolution to allow mea-347 surements at the single cell level, allowing insights into metabolic heterogeneity within T cell populations.
348
Additionally, the high spatial resolution and non-destructive nature of autofluorescence imaging maintains 349 the spatial integrity of immune cells, allowing high fidelity measurements on neighboring cells as demon-350 strated in the combined population of quiescent and activated T cells (Fig. 5A ). Finally, autofluorescence 351 imaging also has high temporal resolution (Fig. 5F ) allowing time-course study of T cell activation. Alto- Technologies). Approximately 24 hours post-isolation, the T cells were divided into two groups, a "quiescent" 366 population that was grown in medium without activating antibodies, and an "activated" population that was 367 cultured in medium supplemented with 25 µl/ml tetrameric antibody against CD2/CD3/CD28 (StemCell 368 Technologies). Quiescent and activated T cell populations were cultured separately for 48 hours at 37°C, 369 5% CO 2 , and 99% humidity before imaging and subsequent experiments, unless otherwise noted. Prior to 
